Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 245395, 5 pages
http://dx.doi.org/10.1155/2013/245395
Case Report

Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge

1Department of Hematology, “Tor Vergata” University, Viale Oxford 81, 00133 Rome, Italy
2Department of Otorhinolaryngology, “Tor Vergata” University, Viale Oxford 81, 00133 Rome, Italy

Received 13 June 2013; Accepted 13 August 2013

Academic Editors: E. Arellano-Rodrigo, N. Hamerschlak, K. Konstantopoulos, S. Storti, and S. Tauro

Copyright © 2013 Ambra Di Veroli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Wiernik and A. A. Serpick, “Granulocytic sarcoma (chloroma),” Blood, vol. 35, no. 3, pp. 361–369, 1970. View at Google Scholar · View at Scopus
  2. H. B. Muss and W. C. Moloney, “Chloroma and other myeloblastic tumors,” Blood, vol. 42, no. 5, pp. 721–728, 1973. View at Google Scholar · View at Scopus
  3. Y.-Y. Lai, J.-Y. Qiu, B. Jiang et al., “Characteristics and prognostic factors of acute myeloid leukemia with t(8;21) (q22; q22),” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 13, no. 5, pp. 733–740, 2005. View at Google Scholar · View at Scopus
  4. T. Kyo, “Characteristic clinical features and treatment of acute myelocytic leukemia with 8;21 translocation,” Rinsho Ketsueki, vol. 35, no. 3, pp. 245–249, 1994. View at Google Scholar · View at Scopus
  5. H. Kiyoi, T. Naoe, Y. Nakano et al., “Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia,” Blood, vol. 93, no. 9, pp. 3074–3080, 1999. View at Google Scholar · View at Scopus
  6. R. S. Care, P. J. M. Valk, A. C. Goodeve et al., “Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias,” British Journal of Haematology, vol. 121, no. 5, pp. 775–777, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Moreno, G. Martín, P. Bolufer et al., “Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia,” Haematologica, vol. 88, no. 1, pp. 19–24, 2003. View at Google Scholar · View at Scopus
  8. R. Schwyzer, G. G. Sherman, R. J. Cohn, J. E. Poole, and P. Willem, “Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21),” Medical and Pediatric Oncologyl, vol. 31, no. 3, pp. 144–149, 1998. View at Google Scholar
  9. H. Bönig, U. Göbel, and W. Nürnberger, “Bilateral exophthalmus due to retro-orbital chloromas in a boy with t(8;21)-positive acute myeloblastic leukemia,” Pediatric Hematology and Oncology, vol. 19, no. 8, pp. 597–600, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. W. House and D. E. Brackmann, “Facial nerve grading system,” Otolaryngology, vol. 93, no. 2, pp. 146–147, 1985. View at Google Scholar · View at Scopus
  11. H. Rappaport, Tumors of the Hematopoietic System, Atlas of Tumor Pathology, Armed Forces Institutes of Pathology, Washington, DC, USA, 1966.
  12. S. J. Slomowitz and P. J. Shami, “Management of extramedullary leukemia as a presentation of acute myeloid leukemia,” Journal of the National Comprehensive Cancer Network, vol. 10, no. 9, pp. 1165–1169, 2012. View at Google Scholar
  13. D. Mangla, M. Dewan, and D. R. Meyer, “Adult orbital myeloid sarcoma (granulocytic sarcoma): two cases and review of the literature,” Orbit, vol. 31, no. 6, pp. 438–440, 2012. View at Google Scholar
  14. M. Rizwan, M. M. Islam, and Z. U. Rehman, “Granulocytic sarcoma of the male breast in acute myeloblastic leukemia with concurrent deletion of 5q and trisomy 8,” Case Reports in Hematology, vol. 2012, Article ID 194312, 5 pages, 2012. View at Publisher · View at Google Scholar
  15. W. Zhao, H. W. Shi, and G. H. Zhu, “Myeloid sarcoma of the spine: a case report and literature review,” Zhonghua Xue Ye Xue Za, vol. 32, no. 1, pp. 58–60, 2011. View at Google Scholar
  16. J. Imagawa, Y. Harada, T. Yoshida et al., “Giant granulocytic sarcoma of the vagina concurrent with acute myeloid leukemia with t(8;21)(q22;q22) translocation,” International Journal of Hematology, vol. 92, no. 3, pp. 553–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. V. M. de Arruda Câmara, J. C. Morais, R. Portugal, S. C. da Silva Carneiro, and M. Ramos-E-Silva, “Cutaneous granulocytic sarcoma in myelodysplastic syndrome,” Journal of Cutaneous Pathology, vol. 35, no. 9, pp. 876–879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Pileri, S. Ascani, M. C. Cox et al., “Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients,” Leukemia, vol. 21, no. 2, pp. 340–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. A. Alexiev, W. Wang, Y. Ning et al., “Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study,” Diagnostic Pathology, vol. 2, no. 1, article 42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Y. Hurley, G. K. Ghahramani, S. Frisch et al., “Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia,” Acta Dermato-Venereologica, vol. 93, no. 3, pp. 319–324, 2012. View at Publisher · View at Google Scholar
  21. C. Thiede, C. Steudel, B. Mohr et al., “Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis,” Blood, vol. 99, no. 12, pp. 4326–4335, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. D. Kottaridis, R. E. Gale, M. E. Frew et al., “The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials,” Blood, vol. 98, no. 6, pp. 1752–1759, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Almadori, M. del Ninno, G. Cadoni, A. di Mario, and F. Ottaviani, “Facial nerve paralysis in acute otomastoiditis as presenting symptom of FAB M2, T8;21 leukemic relapse. Case report and review of the literature,” International Journal of Pediatric Otorhinolaryngology, vol. 36, no. 1, pp. 45–52, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Karimi, N. Cohan, S. Zareifar, S. Inaloo, S. Kalikias, and S. Moslemi, “Initial presentation of childhood leukaemia with facial palsy: three case reports,” BMJ Case Reports, vol. 2009, 2009. View at Google Scholar
  25. M. Crovetto, J. A. Márquez, C. Ereño, J. Elexpuru, R. Crovetto, and A. Martinez, “Granulocytic sarcoma presenting as atypical mastoiditis with facial paralysis: description of a case,” Case Reports in Otolaryngology, vol. 2011, Article ID 191852, 3 pages, 2011. View at Publisher · View at Google Scholar
  26. L. Pacilli, F. lo Coco, S. M. Ramadan et al., “Promyelocytic sarcoma of the spine: a case report and review of the literature,” Advances in Hematology, vol. 2010, Article ID 137608, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Seok, J. Park, S. K. Kim, J. E. Choi, and C.-C. Kim, “Granulocytic sarcoma of the spine: MRI and clinical review,” American Journal of Roentgenology, vol. 194, no. 2, pp. 485–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Jerse, U. Mlakar, M. Popovic, A. Vranic, and N. Zidar, “Granulocytic sarcoma in a patient with essential thrombocythemia presented as acute spinal cord compression—case report and review of the literature,” Clinical Neuropathology, vol. 27, no. 4, pp. 241–247, 2008. View at Google Scholar · View at Scopus
  29. E. Balleari, S. Panarello, E. Capello et al., “Granulocytic sarcoma: an unusual cause of spinal cord compression,” International Journal of Clinical Oncology, vol. 12, no. 3, pp. 234–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-C. Chang, C. Eshoa, B. Kampalath, V. B. Shidham, and S. Perkins, “Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry: correlation with blast differentiation in bone marrow,” American Journal of Clinical Pathology, vol. 114, no. 5, pp. 807–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. L. P. Menasce, S. S. Banerjee, E. Beckett, and M. Harris, “Extra-medullary myeloid tumour (Granulocytic sarcoma) is often misdiagnosed: a study of 26 cases,” Histopathology, vol. 34, no. 5, pp. 391–398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. J. D. Hoyer, K. L. Grogg, C. A. Hanson, J. D. Gamez, and A. Dogan, “CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage,” American Journal of Clinical Pathology, vol. 129, no. 2, pp. 316–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Klco, J. S. Welch, T. T. Nguyen et al., “State of the art in myeloid sarcoma,” International Journal of Laboratory Hematology, vol. 33, no. 6, pp. 555–565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Shimizu, T. Saitoh, M. Tanaka et al., “Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma,” Leukemia, vol. 26, no. 12, pp. 2469–2473, 2012. View at Google Scholar